Modafinil disrupts prepulse inhibition in mice: Strain differences and involvement of dopaminergic and serotonergic activation

European Journal of Pharmacology

Volumn 699, Issue 1-3, 2013, Pages 132-140

  Kwek, Perrin ^a   Van Den Buuse, Maarten ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Dopamine; Modafinil; Prepulse inhibition; Schizophrenia; Serotonin; Startle

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; FLUOXETINE; HALOPERIDOL; KETANSERIN; MODAFINIL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 2A RECEPTOR; VANOXERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG MECHANISM; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RECEPTOR BLOCKING; SENSORY GATING; SEROTONINERGIC NERVE CELL; STARTLE REFLEX; STRAIN DIFFERENCE;

ADMINISTRATION, ORAL; ANIMALS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; SENSORY GATING; SPECIES SPECIFICITY; STARTLE REACTION;

EID: 84871917019     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.041     Document Type: Article

References (43)

1. 2-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance J. Pharmacol. Exp. Ther. 320 2007 376 385
2. M.B. Assié, H. Dominguez, N. Consul-Denjean, and A. Newman-Tancredi In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles Naunyn-Schmied. Arch. Pharmacol. 373 2006 441 450
3. P.P. Bertrand, U.T. Paranavitane, C. Chavez, A. Gogos, M. Jones, and M. van den Buuse The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study Brain Res. 1064 2005 10 20
4. A.M. Bradford, K.M. Savage, D.N. Jones, and M. Kalinichev Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/c mice as an assay for detection of novel antipsychotics Psychopharmacology 212 2010 155 170
5. Z. de Saint Hilaire, M. Orosco, C. Rouch, G. Blanc, and S. Nicolaidis Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats Neuroreport 12 2001 3533 3537
6. L. Ferraro, K. Fuxe, L. Agnati, S. Tanganelli, M.C. Tomasini, and T. Antonelli Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat Synapse 55 2005 230 241
7. 2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats J. Neurochem. 61 1993 772 775
8. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 2001 117 154
9. S.D. Gleason, and H.E. Shannon Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice Psychopharmacology 129 1997 79 84
10. K.G. Heinzerling, A.N. Swanson, S. Kim, L. Cederblom, A. Moe, W. Ling, and S. Shoptaw Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence Drug Alcohol Depend. 109 2010 20 29
11. T. Ishizuka, M. Murakami, and A. Yamatodani Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats Euro. J. Pharmacol. 578 2008 209 215
12. 2-like receptors Neuropharmacology 52 2007 626 633
13. 2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats Psychopharmacology 189 2006 319 329
14. R. Kumar Approved and investigational uses of modafinil: an evidence-based review Drugs 68 2008 1803 1839
15. Y.P. Liu, C.S. Tung, C.H. Chuang, S.M. Lo, and Y.C. Ku Tail-pinch stress and REM sleep deprivation differentially affect sensorimotor gating function in modafinil-treated rats Behav. Brain Res. 219 2011 98 104
16. Z.Q. Ma, Z.Y. Hong, W.S. Wang, and F. Tao Pharmacokinetics - pharmacodynamics of modafinil in mice Yao Xue Xue Bao 47 2012 101 104
17. J. Martinez-Raga, C. Knecht, and S. Cepeda Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies Curr. Drug Abuse Rev. 1 2008 213 221
18. J. McCaughran, E. Mahjubi, E. Decena, and R. Hitzemann Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition Psychopharmacology 134 1997 131 139
19. S.L. McFadden, A.L. Zulas, and R.E. Morgan Age-dependent effects of modafinil on acoustic startle and prepulse inhibition in rats Behav. Brain Res. 208 2010 118 123
20. A.J. Mcgeehan, P.H. Janak, and M.F. Olive Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, d-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice Psychopharmacology 174 2004 266 273
21. M.J. Minzenberg, and C.S. Carter Modafinil: a review of neurochemical actions and effects on cognition Neuropsychopharmacology 33 2008 1477 1502
22. S. Morein-Zamir, D.C. Turner, and B.J. Sahakian A review of the effects of modafinil on cognition in schizophrenia Schizophr. Bull. 33 2007 1298 1306
23. R. Paylor, and J.N. Crawley Inbred strain differences in prepulse inhibition of the mouse startle response Psychopharmacology 132 1997 169 180
24. 2 receptors are essential for the arousal effect of modafinil J. Neurosci. 28 2008 8462 8469
25. M. Raineri, V. Peskin, B. Goitia, I.R.E. Taravini, S. Giorgeri, F.J. Urbano, and V. Bisagno Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice Synapse 65 2011 1087 1098
26. R.N. Rao, and D.D. Shinde Enantioselective separation and determination of adrafinil and modafinil on Chiralcel OJ-H column in rat serum and urine using solid-phase extraction followed by HPLC Med. Chromatogr. 23 2009 811 816
27. R. Regenthal, H. Koch, C. Kohler, R. Preiss, and U. Krugel Depression-like deficits in rats improved by subchronic modafinil Psychopharmacology 204 2009 627 639
28. C. Saavedra-Velez, A. Yusim, D. Anbarasan, and J.P. Lindenmayer Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review J. Clin. Psychiatry 70 2009 104 112
29. E.R. Samuels, R.H. Hou, R.W. Langley, E. Szabadi, and C.M. Bradshaw Modulation of the acoustic startle response by the level of arousal: comparison of clonidine and modafinil in healthy volunteers Neuropsychopharmacology 32 2007 2405 2421
30. A. Schotte, P.F.M. Janssen, A.A.H.P. Megens, and J.E. Leysen Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography Brain Res. 631 1994 191 202
31. P. Simon, C. Hemet, and J. Costentin Analysis of stimulant locomotor effects of modafinil in various strains of mice and rats Fundam. Clin. Pharmacol. 10 1996 431 435
32. P. Simon, C. Hémet, C. Ramassamy, and J. Costentin Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice Eur. Neuropsychopharmacol. 5 1995 509 514
33. N.R. Swerdlow, J. Talledo, A.N. Sutherland, D. Nagy, and J.M. Shoemaker Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats Neuropsychopharmacology 31 2006 2011 2021
34. N.R. Swerdlow, M. Weber, Y. Qu, G.A. Light, and D.L. Braff Realistic expectations of prepulse inhibition in translational models for schizophrenia research Psychopharmacology 199 2008 331 338
35. 1A receptor antagonist, on 8-OH-DPAT responses Eur. J. Pharmacol. 347 1998 41 49
36. C. Vadasz, J.F. Smiley, K. Figarsky, M. Saito, R. Toth, B.M. Gyetvai, M. Oros, K.K. Kovacs, P. Mohan, and R. Wang Mesencephalic dopamine neuron number and tyrosine hydroxylase content: genetic control and candidate genes Neuroscience 149 2007 561 572
37. M. van den Buuse Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects Schizophr. Bull. 36 2010 246 270
38. 1A receptor stimulation, which are strongly dependent on the genetic background Psychopharmacology 195 2007 273 283
39. N.D. Volkow, J.S. Fowler, J. Logan, D. Alexoff, W. Zhu, F. Telang, G.J. Wang, M. Jayne, J.M. Hooker, C. Wong, B. Hubbard, P. Carter, D. Warner, P. King, C. Shea, Y. Xu, L. Muench, and K. Apelskog-Torres Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications J. Am. Med. Assoc. 201 2009 1148 1154
40. 2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval Neuropsychopharmacology 32 2007 1876 1887
41. 1 receptors? Biol Psychiatry 67 2010 784 787
42. J.W. Young, A.K.L. Goey, A. Minassian, W. Perry, M.P. Paulus, and M.A. Geyer GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior Psychopharmacology 208 2010 443 454
43. D. Zolkowska, R. Jain, R.B. Rothman, J.S. Partilla, B.L. Roth, V. Setola, T.E. Prisinzano, and M.H. Baumann Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil J. Pharmacol. Exp. Ther. 329 2009 738 746